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1. INTRODUCTION (ii) Reversible interconversion of the monomeric 
CNPase into a high-Mr enzyme form. 
Membrane-bound 2’,3’-cyclic nucleotide 3’- 
phosphodiesterase activity (CNPase, EC 3.1.4.37) 
is most prominent in the mammalian central 
nervous system but low levels of CNPase activity 
have also been detected in other mammalian 
tissues as well as in bacteria (review [l]). A great 
variety of estimations has been reported for bovine 
brain CNPase, 30 000-100 000 M, [2-81. This di- 
versity in M, has been investigated in detail by 
limited proteolytic digestion, plant lectin affinity 
chromatography and immunochemical analysis [9] 
using purified bovine brain CNPase isolated as in 
[lo]. Under reducing conditions: the enzyme resolves 
into a polypeptide doublet (Mr 51 000-54 000) 
in SDS-polyacrylamide gels [ 11. Two catalytically 
active molecular forms of CNPase were identified: 
a low-M, form of the enzyme (Mr -50 000) and a 
high-Mri, form (M, - 100 000) providing evidence 
for a monomer-dimer relationship in CNPase [ 11. 
Furthermore, the specific activities of both CNPase 
forms are compared and the molecular form of the 
enzyme possibly occurring in vivo is discussed. 
2. MATERIALS AND METHODS 
2’,3’-Cyclic nicotinamide-adenine dinucleotide 
phosphate (2’,3’-cNADP), bovine serum albumin 
(BSA), carbonic anhydrase and 1 ,Cdithiothreitol 
(DTT) were purchased from Sigma Chemical Co. 
(St Louis MO). Urea was produced by Bio-Rad 
Lab. (Richmond CA). Human y-globulin was ob- 
tained from Miles Lab. (Elkhart IL) and all othei 
chemicals used were of analytical grade purchased 
from Merck (Darmstadt). 
These experiments support our hypothesis as they 
demonstrate the presence of covalent and non-co- 
valent interactions between the subunits in the 
high-Mr form of CNPase. Experiments are de- 
Rapid isolation of CNPase from bovine brain 
white matter was performed under non-reducing 
conditions by guanidinium-HCl extraction and 
carboxymethyl-Sephadex column chromato- 
graphy as in [lo]. 
CNPase activity was estimated using 
2’,3’-cNADP as substrate in the combined enzyme 
assay [ 111. One unit (U) of CNPase is defined as the 
amount of enzyme that produces 1 pmol product 
(2’-NADP)/min at 37°C in 50 mM sodium acetate 
buffer (pH 5.5). Protein was measured as in [ 121. 
s&bed in which were observed:- 
(i) Nearly complete dissociation 
CNPase dimer into catalytically 
mers; and 
of purified 
active mono- 
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Sedimentation rate analyses were carried out by 
centrifugation of CNPase in linear 32 ml sucrose 
density gradients (IO-35%, w/v). All gradients were 
prepared in 50 mM 2-(N-morpholino)-ethane 
sulphonic acid-NaOH (MES-NaOH) buffer (pH 
6.4) containing 1 mM EDTA and centrifuged at 
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81 500 X gav for 43 h in a Beckman SW27 rotor. 
Some sucrose gradients contained 1 mM DTT. 
Fractions of 1 ml were collected. Molecular mass 
estimations were based on co-centrifugation of 
protein standards: human y-globulin (M, 150 000) 
BSA (Mr 68 000) and carbonic anhydrase (M, 
29 000). 
a) CNParr alone 
3. RESULTS AND DISCUSSION 
Sedimentation rate analyses of isolated bovine 
brain CNPase (spec. act. 700 U/mg protein) were 
performed in linear sucrose density gradients under 
both non-reducing and reducing conditions. Fig. 1 a 
represents the activity profile of purified CNPase in 
a sucrose gradient centrifuged under non-reducing 
conditions. The peak activity corresponds to app. M, 
100 000 (100 kDa). An additional but minor 
shoulder of activity appears at > 150 000 M,. The 
100 kDa CNPase activity, as indicated by (D), has 
recently been identified by gel filtration as the high- 
M, enzyme form being composed of two poly- 
peptide chains (M, 51 000-54 000) [ 11. However, 
in the presence of a large molar excess of the re- 
ducing agent DTT (1 mM) two peaks of CNPase 
activity appeared in the sucrose gradient (fig.lb), 
corresponding to the Mr-values of 100 kDa (D) and 
50 kDa (M), respectively. This indicates that the 
enzyme activity obtained in a single peak at 100 kDa 
under non-reducing conditions (fig. la) is partially 
dissociated by the thiol reagent and shifted towards 
a lower M, (50 000). At 1 mM, DTT has no effect on 
the catalytical activity of CNPase since the total 
activities remained almost unchanged in both grad- 
ients (tig.la,b). This result further implies that the 
specific activities of both enzyme forms were 
roughly identical as the same amount of enzyme (30 
pg protein) was applied on both sucrose gradients. 
The - 50 000 M, estimated for the CNPase activity 
peak (M) after partial dissociation of the high-M, 
form of the enzyme corresponds with the low-M, 
form in [l] and agrees with the M,-values of the 
polypeptide subunits of brain CNPase estimated in 
SDS-polyacrylamide gels under reducing condi- 
tions [I]. These results indicate that the 50 kDa 
CNPase form represents a catalytically active 
monomer (M), consisting of a single polypeptide 
chain, whereas the 100 kDa enzyme form represents 
a dimer (D). 
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Fig. 1. Activity profiles of bovine brain CNPase after su- 
crose density gradient centrifugation: (a) under non-re- 
ducing conditions; (b) in the presence of 1 mM DDT; and 
(c) in the presence of 1 mM DTT after preincubation of 
the enzyme protein in I mM DDT and 5 M urea for 30 
min and subsequent dialysis. (D) and (M) indicate di- 
meric and monomeric enzyme forms, respectively. 
Sample volumes of 1 ml containing 30 ).6g enzyme protein 
(spec. act. 700 U/mg) were applied on each gradient. The 
Mr-marker proteins (human y-globulin, BSA and car- 
bonic anhydrase) were run in parallel gradient tubes and 
the positions of their peak maxima are indicated in (a). 
Nearly complete dissociation of CNPase dimer Further details are given in section 2. 
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into monomers (M) occurred upon incubation of 
purified CNPase in the presence of both DTT (1 
mM) and urea (5 M) at 25°C for 30 min prior to 
dialysis to remove urea and sucrose gradient cen- 
trifugation (figlc). Urea at 5 M totally inhibits 
CNPase activity. However, the inhibition is revers- 
ible and the enzyme activity can be restored by 
dialysis so that there is no substantial change in 
enzyme activity (see fig.lc) when compared to the 
gradients in fig.la and lb. Urea alone is unable to 
dissociate the CNPase subunits (not shown). 
From [l] a reaggregation of CNPase monomers 
(50 kDa) to form the 100-kDa enzyme complex 
would be predicted. To investigate the reversibility 
of the interconversion of both enzyme forms, 5 
gradient fractions were pooled from the activity 
peak (M) in fig. 1 b as indicated by the bar (total vol. 
5 ml, 10 units of CNPase activity). DTT and sucrose 
were removed by dialysis (4”C, 15 h) against 2 X 
500 ml 50 mM MES-NaOH buffer (pH 6.4) con- 
taining 1 mM EDTA. The dialyzed enzyme sample 
was then divided into two halves and each fraction 
was rerun on a separate sucrose gradient either in 
the absence or in the presence of BSA. When BSA 
was omitted the main peak (M) of CNPase activity 
appeared at the same position (50 kDa) in the 
sucrose gradient (fig.2a) as compared to the origin- 
al fractions (M) in fig.1 b, indicating that CNPase 
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Fig.2. Sucrose density gradient centrifugation of mono- 
meric CNPase: (a) in the absence of additional protein; 
or(b) in the presence of 10 mg BSA/ml; (O-O) CNPase 
activity; (O-O) protein concentration. Further details 
are described in sections 2 and 3. 
monomers do not spontaneously reassemble into a 
dimer after removal of the reducing agent (air- 
oxidation). However, in the presence of 10 mg 
BSA/ml added to the enzyme sample prior to centri- 
fugation, two main peaks of CNPase activity were 
resolved in the gradient (fig.2b). The peak activities 
correspond to - 100 000 M, (D) and 50 000 M, (M) 
showing the reappearance of the high-M, enzyme 
form upon partial reaggregation of monomers. The 
latter result corroborates our finding that various 
proteins, among which is found BSA, may cause the 
(partial) conversion of the 50-kDa CNPase form 
into the lOO-kDa enzyme [ 11. 
The CNPase activity recovered in the gradient of 
fig.2a represented only - 50% (2.5 U) of the expec- 
ted activity. This loss in enzyme activity might be 
due to precipitation indicated by the small peak of 
(residual) activity near the bottom of the gradient 
tube. However, the presence of BSA in the enzyme 
sample (fig.2b) caused not only the reappearance of 
the high-M, CNPase form (D) but also stimulated 
the enzyme up to a total activity of 10 U. This value 
represents a 2-fold stimulation over the expected 
activity of 5 U but when compared with the corre- 
sponding enzyme fraction centrifuged in the ab- 
sence of additional protein (fig.2a) the CNPase ac- 
tivity is stimulated 4-fold in the presence of BSA. 
Bovine brain CNPase, isolated under non-reduc- 
ing conditions, is a protein dimer made up of two 
50-kDa polypeptide subunits. The dimeric struct- 
ure of the enzyme is easily dissociated by DTT and 
urea suggesting the presence of intersubunit disul- 
fide bridges and hydrogen bonds necessary for 
maintaining the quarternary structure. The mono- 
meric enzyme form thus obtained is catalytically 
active and stable; however, the CNPase dimer 
seems to be the form of the enzyme found in vivo in 
brain. It cannot be ruled out that there may exist 
even larger complexes of the enzyme in this tissue 
(see also fig. la) which were not isolated by the pres- 
ent preparation method which included guanid- 
inium hydrochloride extraction. From the almost 
identical specific activities observed for both 
enzyme forms (fig.la, lc) it can. further be con- 
cluded that the number of catalytic sites remained 
unchanged upon dissociation of the dimer into 
monomers. 
Knowledge of the nature of the bonds involved in 
the stabilization of the quarternary structure of ihe 
CNPase dimer and the availability of an enzymati- 
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tally active monomeric enzyme also suggest that 
reversible interconversion of both enzyme moieties 
may be useful in the evaluation of its still unknown 
biological function in the central nervous system. In 
[l] we outlined common biochemical properties 
shared by CNPase and RNAase and suggested a 
possible function of CNPase in the RNA metab- 
olism. A similar type of CNPase activity processing 
RNA in wheat germ has been described in [ 131. 
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